Azaindolylpyridone and diazaindolylpyridone compounds
US11498919B2 · kind B2 · utility
0Cited by
1References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 23, 2018 |
| Grant date | Nov 15, 2022 |
| Priority date | — |
| Expiry date | May 20, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N5/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides novel azaindolylpyridone and diazaindolylpyridone compounds of formula (I), pharmaceutical compositions containing such compounds, and methods for using such compounds in treatment of diseases including cancer, type II diabetes, inflammatory diseases, autoimmune diseases, neurodegenerative disorders, cardiovascular disorders and viral infections; wherein R2, R3 and X are as defined in the specification.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.